BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8282820)

  • 1. Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors.
    Anand G; Shapiro DN; Dickman PS; Prochownik EV
    J Clin Invest; 1994 Jan; 93(1):5-9. PubMed ID: 8282820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR; Richardson JA; Klein WH; Olson EN
    Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.
    Rawls A; Morris JH; Rudnicki M; Braun T; Arnold HH; Klein WH; Olson EN
    Dev Biol; 1995 Nov; 172(1):37-50. PubMed ID: 7589813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A point mutation in the MyoD basic domain imparts c-Myc-like properties.
    Van Antwerp ME; Chen DG; Chang C; Prochownik EV
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9010-4. PubMed ID: 1329087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin.
    Wang Y; Schnegelsberg PN; Dausman J; Jaenisch R
    Nature; 1996 Feb; 379(6568):823-5. PubMed ID: 8587605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
    Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
    Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents.
    Rohwedel J; Maltsev V; Bober E; Arnold HH; Hescheler J; Wobus AM
    Dev Biol; 1994 Jul; 164(1):87-101. PubMed ID: 8026639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD.
    Friday BB; Mitchell PO; Kegley KM; Pavlath GK
    Differentiation; 2003 Apr; 71(3):217-27. PubMed ID: 12694204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.
    Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC
    J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis.
    Tapscott SJ; Thayer MJ; Weintraub H
    Science; 1993 Mar; 259(5100):1450-3. PubMed ID: 8383879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle.
    Davie JK; Cho JH; Meadows E; Flynn JM; Knapp JR; Klein WH
    Dev Biol; 2007 Nov; 311(2):650-64. PubMed ID: 17904117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of myogenic regulating factors, Myogenin and MyoD, in two canine botryoid rhabdomyosarcomas.
    Kobayashi M; Sakai H; Hirata A; Yonemaru K; Yanai T; Watanabe K; Yamazoe K; Kudo T; Masegi T
    Vet Pathol; 2004 May; 41(3):275-7. PubMed ID: 15133178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility.
    Dias P; Parham DM; Shapiro DN; Tapscott SJ; Houghton PJ
    Cancer Res; 1992 Dec; 52(23):6431-9. PubMed ID: 1384962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation.
    La Rocca SA; Crouch DH; Gillespie DA
    Oncogene; 1994 Dec; 9(12):3499-508. PubMed ID: 7970710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family.
    Downes M; Carozzi AJ; Muscat GE
    Mol Endocrinol; 1995 Dec; 9(12):1666-78. PubMed ID: 8614403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice.
    Kassar-Duchossoy L; Gayraud-Morel B; Gomès D; Rocancourt D; Buckingham M; Shinin V; Tajbakhsh S
    Nature; 2004 Sep; 431(7007):466-71. PubMed ID: 15386014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.
    Tonin PN; Scrable H; Shimada H; Cavenee WK
    Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family.
    Bergstrom DA; Tapscott SJ
    Mol Cell Biol; 2001 Apr; 21(7):2404-12. PubMed ID: 11259589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.